Onderzoeker
Pieter Gillard
- Trefwoorden:Geneeskunde
Affiliaties
- Diabetes Pathologie & Therapie (Onderzoeksgroep)
Lid
Vanaf2 feb 2011 → Heden - Artsen Diabeteskliniek (Departement)
Lid
Vanaf1 nov 2008 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 okt 2023 → Heden - Pathologie/moleculaire en cellulaire geneeskunde (Departement)
Lid
Vanaf1 okt 2018 → 20 okt 2022 - Pathologie/moleculaire en cellulaire geneeskunde (Departement)
Lid
Vanaf1 aug 2014 → 30 sep 2023 - Pathologie/moleculaire en cellulaire geneeskunde (Departement)
Lid
Vanaf1 aug 2014 → 31 jul 2018 - Interne Geneeskunde (Departement)
Lid
Vanaf1 jan 2008 → 31 jan 2008 - Embryologie en Menselijke Genetica (Departement)
Lid
Vanaf1 feb 2002 → 31 jan 2006
Publicaties
1 - 10 van 66
- Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium(2024)
Auteurs: Margaretha M Visser, Astrid Van Muylder, Sara Charleer, John J Isitt, Stéphane Roze, Christophe De Block, Toon Maes, Gerd Vanhaverbeke, Frank Nobels, Bart Keymeulen, et al.
Pagina's: 650-662 - Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes(2023)
Auteurs: Aster K Desouter, Bart Keymeulen, Simke Demeester, Pieter De Pauw, Annelien Van Dalem, Bruno Lapauw, Christophe De Block, Pieter Gillard, Danny Pipeleers, Frans K Gorus
- Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes(2023)
Auteurs: Valeria Sordi, Paolo Monti, Vito Lampasona, Raffaella Melzi, Silvia Pellegrini, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, et al.
- CTLA4, SH2B3 and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of type 1 diabetes patients(2023)
Auteurs: Julie Vandewalle, Aster K Desouter, Bart J Van der Auwera, Sylvie Tenoutasse, Pieter Gillard, Christophe De Block, Bart Keymeulen, Frans K Gorus, Mark Van de Casteele
Pagina's: 224-232 - Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes(2023)
Auteurs: Margaretha M Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, et al.
Pagina's: 96-108 - Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population(2022)
Auteurs: Francesca De Ridder, Sara Charleer, Seppe Jacobs, Nancy Bolsens, Kristien J. Ledeganck, Sara Van Aken, Jesse Vanbesien, Inge Gies, Kristina Casteels, Guy Massa, et al.
- Diabetic Ketoacidosis After Sodium–Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 Diabetes(2022)
Auteurs: Margaretha M Visser, Chantal Mathieu, Pieter Gillard
Pagina's: 516-519 - Utility of islet cell preparations from donor pancreases after euthanasia(2022)
Auteurs: Diedert L De Paep, Freya Van Hulle, Zhidong Ling, Marian Vanhoeij, Robert Hilbrands, Wim Distelmans, Pieter Gillard, Bart Keymeulen, Daniel Pipeleers, Daniel Jacobs-Tulleneers-Thevissen
Pagina's: 9636897221096160 - Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use(2022)
Auteurs: Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, Pieter Gillard, Richard J MacIsaac, Julio Wainstein, et al.
Pagina's: 888-897 - Cardiometabolic and Kidney Protection in Kidney Transplant Recipients with Diabetes(2022)
Auteurs: Vikas S Sridhar, Jaya Prakash N Ambinathan, Pieter Gillard, Chantal Mathieu, David Z I Cherney, Yuliya Lytvyn, Sunita K Singh
Pagina's: 734-748